Cornelius P. McCarthy III insider trades: Medpace Holdings (MEDP) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Cornelius reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | MEDP | ↓ Sell | 1,140 | $605.37 | $690K | Direct | Aug 13, 2026 (2d) |
| Aug 7, 2026 | MEDP | ↓ Sell | 795 | $585.07 | $465K | Direct | Aug 11, 2026 (4d) |
| Aug 19, 2025 | MEDP | ↓ Sell | 1,662 | $465.04 | $773K | Direct | Aug 21, 2025 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MEDP insiders
Open-market trades in the last 12 months
About Cornelius P. McCarthy III's insider trades
Cornelius P. McCarthy III is a director at Medpace Holdings (MEDP). Since Aug 19, 2025, Cornelius has reported no open-market purchases and 3 sales worth $1.9M on SEC Form 4. In the last 12 months: 2 sales ($1.2M).
Their filings also include option exercises (18 filings), grants and awards (12 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MEDP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.